- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05480839
Manual Immediately Sequential Bilateral Cataract Surgery (M-ISBCS) vs Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery (ReLA-ISBCS)
July 27, 2022 updated by: Uptown Eye Specialists
A Comparison of Patient Perceptions Undergoing Manual Immediately Sequential Bilateral Cataract Surgery (M-ISBCS) vs Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery (ReLA-ISBCS)
The focus of this study is to assess the differences in patient perceptions of pain undergoing cataract surgery by using the Refractive Laser-Assisted Cataract Surgery (ReLACS) technique compared to the standard Manual Cataract Surgery (MCS) technique using an immediately sequential bilateral approach.
This study also aims to further explore difference in patients' perceptions of pain depending on timing of neurolept anesthesia in the ReLACS technique.
The importance of this study is appreciated patient perception of pain during ReLACS, which is an emerging technique for cataract surgery and has been sparsely reported on to date.
This investigation will include the analysis of various surgical, ocular, medical, and psychosocial metrics of patients undergoing both ReLACS and MCS at Uptown Eye specialist.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Brampton, Ontario, Canada, L6Y0P6
- Recruiting
- Uptown Eye Specialist
-
Contact:
- Sohel Somani, MD, FRCSC
- Phone Number: 4162920330
- Email: sohel@uptowneye.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing uncomplicated cataract surgery with either surgical technique (M-ISBCS or ReLA-ISBCS)
- Patients who require surgery in both eyes by the same surgeon
- Able to understand English and complete a pain assessment (NRS)
Exclusion Criteria:
- Deafness or communication disorder, known Dementia, Severe COPD/Asthma (severe lung disorder), Severe OSA, Psychiatric or Anxiety conditions, involuntary movement disorders, allergy to the anesthesia, any conditions requiring intraoperative iris manipulation, any prior ocular surgery
- Pre-existing chronic eye pain or uveitis, or complicated cataracts (dislocation, zonulopathy)
- Pre-existing uncontrolled glaucoma/high IOP
- Intraoperative complications or non-routine cataracts (eg. Sutures, excessive time of surgery)
- Any patient who requires Deep Sedation (Propofol), GA or preOP Ativan
- Patients under 40, severe obesity (BMI >35)
- Chronic pain/narcotics/recreational or medical marijuana
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Manual Immediately Sequential Bilateral Cataract Surgery (MCS)
|
Manual Cataract Surgery - Phacoemulsification: removal of the eye lens and insertion of an intraocular lens implant
|
|
Experimental: Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery (ReLA-ISBCS) Early
|
Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery - ReLA-IBSCS with early administration of anesthesia
|
|
Experimental: Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery (ReLA-ISBCS) Standard
|
Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery - ReLA-IBSCS with standard administration of anesthesia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Perception between Manual Immediately Sequential Bilateral Cataract Surgery (M-ISBCS) and Refractive Laser-Assisted Immediately Sequential Cataract Surgery (ReLA-ISCS)
Time Frame: 1 year
|
Pain perceptions of patients undergoing M-IBCS vs ReLA-ISBCS will be measured using the Numerical Rating Scale (NRS) with pain ratings from 0 to 10.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effects of Early vs Standard administration of topical neurolept anesthesia on pain perception
Time Frame: 1 Year
|
Pain perceptions of patients undergoing ReLA-ISBCS Early vs ReLA-ISBCS Standard will be measured using the Numerical Rating Scale (NRS) with pain ratings from 0 to 10.
|
1 Year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Anticipated)
August 31, 2022
Study Completion (Anticipated)
August 31, 2022
Study Registration Dates
First Submitted
July 27, 2022
First Submitted That Met QC Criteria
July 27, 2022
First Posted (Actual)
July 29, 2022
Study Record Updates
Last Update Posted (Actual)
July 29, 2022
Last Update Submitted That Met QC Criteria
July 27, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UptownEye2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MCS vs ReLACS
-
Uptown Eye SpecialistsCompletedMCS vs ReLACS | Early Anesthesia vs Standard Anesthesia | Pain Perception Postoperatively First Eye vs Second EyeCanada
-
International Research Training Group 2804German Research Foundation; Uppsala University; University Hospital TuebingenRecruiting
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
Novartis PharmaceuticalsRecruitingChronic Graft vs. Host Disease | Graft vs. Host Disease | Corticosteroid-refractory Chronic Graft vs. Host DiseaseChina
-
Dr.Mahak MehtaCompletedProseal LMA vs Air-Q LMA vs Ambu AurGain LMA
-
Novartis PharmaceuticalsCompletedCorticosteroid Refractory Acute Graft vs Host DiseaseGermany, Japan, Saudi Arabia, Turkey, United Kingdom, Spain, Canada, Italy, Australia, Austria, France, Korea, Republic of, Hong Kong, Israel, Netherlands, Russian Federation, Denmark, Greece, Taiwan, Norway, Czechia, Bulgaria
-
Central Hospital, Nancy, FranceNot yet recruitingGraft Vs Host DiseaseFrance
-
Boston Children's HospitalBristol-Myers SquibbRecruitingGraft Vs Host DiseaseUnited States
-
Methodist Health SystemCompleted
-
NYU Langone HealthActive, not recruitingGraft Vs Host DiseaseUnited States
Clinical Trials on M-IBCS
-
Hospital Clinic of BarcelonaRecruitingUpper Limb Weakness Due to Central Neurologic Injury | Isquemic StrokeSpain
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma,DLBCLChina
-
Merck Sharp & Dohme LLCCompletedMeasles | Rubella | Mumps | VaricellaFrance, Italy
-
Fundació Institut de Recerca de l'Hospital de la...Sheba Medical Center; iMinds; Semmelweis University; AQuAS, Agència de Qualitat...CompletedSchizophreniaSpain, Hungary, Israel
-
Samueli Institute for Information BiologyWilliam Beaumont Army Medical Center; Palmer Center for Chiropractic Research... and other collaboratorsUnknown
-
Kreiskrankenhaus DormagenCompletedFeasibility of Measurement of a Neuromuscular Block at the m. TrapeziusGermany
-
Tulane UniversityRecruitingDepression | AnxietyUnited States
-
RDC Clinical Pty LtdLallemand Bio-IngredientsCompletedAllergic Rhinitis Due to Grass PollensAustralia
-
CicloMed LLCCmed Clinical ServicesCompletedAdvanced Solid TumorsUnited States
-
Medical University of ViennaNot yet recruitingPain | Acute Pain | Healthy Volunteer Study